| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 08/23/2001 | WO2001060366A1 Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections |
| 08/23/2001 | WO2001060358A1 Method and compositions for treating fibrotic diseases |
| 08/23/2001 | WO2001060355A1 Modulation of bone formation |
| 08/23/2001 | WO2001060349A2 Pharmacological agent comprising picolinic acid, fusaric acid and derivatives thereof. |
| 08/23/2001 | WO2001060278A2 Oral therapeutic delivery appliance |
| 08/23/2001 | WO2001060176A1 Inulin products with improved nutritional properties |
| 08/23/2001 | WO2001024764A3 Cell targeting compositions and methods of using the same |
| 08/23/2001 | WO2001012775A3 25 human secreted proteins |
| 08/23/2001 | WO2001010816A3 Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 08/23/2001 | WO2001008668A3 Use of 2-amino-4-(4-fluoronaphth-1-yl)-6-isopropylpyrimidine in the treatment of gi disorders |
| 08/23/2001 | WO2000078266A3 Interferon tau mutants and methods for making them |
| 08/23/2001 | WO2000059484A3 Use of arylalkanoylpyridazines |
| 08/23/2001 | US20010016660 Reacting difunctional alkanes containing halogen or aliphatic or aromataic sulfonyloxide reactive functional groups with 4-aminopyrimidine derivative in presence of water and organic solvent (alcohols, glycols, polyglycols, mono or diethers) |
| 08/23/2001 | US20010016603 Calcium formate for use as a dietary supplement |
| 08/23/2001 | US20010016596 Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 08/23/2001 | US20010016590 Use of hydroxymatairesinol for prevention of cancers, non-cancer, hormone dependent diseases and cardiovascular diseases by hydroxymatairesinol, and a pharmaceutical preparation, food additive and food product comprising hydroxymatairesinol |
| 08/23/2001 | US20010016583 Therapeutic application of pro-apoptotic benzodiazepines |
| 08/23/2001 | US20010016579 Serotonin 5-HT, receptor partial activator |
| 08/23/2001 | US20010016577 Aqueous liquid containing active ingredient, clay, and a gum; protective coatings; retention; nausea, heartburn, diarrhea; side effect reduction |
| 08/23/2001 | US20010016576 Administering pyrimidine nucleotide precursor where respiratory chain dysfunction is caused by mutation, deletion, or rearrangement of mitochondrial DNA, cytotoxic cancer chemotherapy agents, aging |
| 08/23/2001 | US20010016568 Zinc chelate dimeric cell surface receptor antagonist |
| 08/23/2001 | US20010016336 Genetic engineered polypeptide |
| 08/23/2001 | US20010016207 Compounds such as N-(1-(cyanomethylcarbamoyl)cyclohexyl)-4-(piperazin-1-yl)-benzamide |
| 08/23/2001 | EP1143944A3 Use of arylalkanoylpyridazines |
| 08/23/2001 | CA2651825A1 Substituted arylpyrazines |
| 08/23/2001 | CA2400862A1 Thiazepinyl hydroxamic acid derivatives as matrix metalloproteinase inhibitors |
| 08/23/2001 | CA2400860A1 Aminoalcohol derivatives |
| 08/23/2001 | CA2400634A1 Genetic modification of the lung as a portal for gene delivery |
| 08/23/2001 | CA2400619A1 Purine derivatives |
| 08/23/2001 | CA2400473A1 Her-2 binding antagonists |
| 08/23/2001 | CA2400374A1 Oral, nasal and pulmonary dosage formualtions of copolymer 1 |
| 08/23/2001 | CA2400360A1 Polypeptides and nucleic acids encoding same |
| 08/23/2001 | CA2400332A1 Polypeptides and nucleic acids encoding same |
| 08/23/2001 | CA2400209A1 Oral therapeutic delivery appliance |
| 08/23/2001 | CA2400205A1 Modification of biopolymers for improved drug delivery |
| 08/23/2001 | CA2400021A1 Aryloxyacetic acids for diabetes and lipid disorders |
| 08/23/2001 | CA2399810A1 Modulation of bone formation |
| 08/23/2001 | CA2399705A1 Treatment for bone disorders |
| 08/23/2001 | CA2399198A1 Motilide compounds |
| 08/23/2001 | CA2398937A1 Substituted arylpyrazines |
| 08/23/2001 | CA2398603A1 Fibroblast growth factor-23 molecules and uses thereof |
| 08/23/2001 | CA2397651A1 Amine derivatives for the treatment of apoptosis |
| 08/23/2001 | CA2397233A1 Biarylcarboxamides |
| 08/23/2001 | CA2395854A1 Nucleoside analogs with carboxamidine-modified bicyclic base |
| 08/22/2001 | EP1125944A1 Pluraflavin and derivatives thereof, process for making them as well as their use |
| 08/22/2001 | EP1125925A1 Amine derivatives for the treatment of apoptosis |
| 08/22/2001 | EP1125585A1 Remedies for immunological diseases |
| 08/22/2001 | EP1125507A1 Inulin products with improved nutritional properties |
| 08/22/2001 | EP1124968A2 Library of novel "unnatural" natural products |
| 08/22/2001 | EP1124959A1 Cell surface molecule-induced macrophage activation |
| 08/22/2001 | EP1124951A2 Human sorting nexins |
| 08/22/2001 | EP1124848A2 Transmembrane 4 proteins |
| 08/22/2001 | EP1124845A2 Phosphinate peptide analogs for the treatment of fibrotic disorders |
| 08/22/2001 | EP1124841A1 Bile-acid substituted phenyl alkenoyl guanidines, method for the production thereof, use thereof as medicaments or diagnostic agents and medicaments that contain them |
| 08/22/2001 | EP1124837A2 Novel macrolide antibiotics |
| 08/22/2001 | EP1124828A1 Pyrano, piperidino, and thiopyrano compounds and methods of use |
| 08/22/2001 | EP1124821A1 Compounds |
| 08/22/2001 | EP1124814A1 Aromatic derivatives and iron complexes thereof for the use as normalising agents of the iron level |
| 08/22/2001 | EP1124809A1 Benzoylpyridazines |
| 08/22/2001 | EP1124801A1 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 08/22/2001 | EP1124797A1 N-arylsulfonyl amino acid omega amides |
| 08/22/2001 | EP1124794A1 Substituted 3,3-diamino-2-propenenitriles, their preparation and use |
| 08/22/2001 | EP1124569A2 Composition and method for increasing weight gain and feed efficiency |
| 08/22/2001 | EP1124566A1 Non-fermented osmotic laxative for treating and preventing colorectal cancers |
| 08/22/2001 | EP1124562A1 Combination therapy to treat hepatitis b virus |
| 08/22/2001 | EP1124551A2 Delta 9 tetrahydrocannabinol (delta 9 thc) solution metered dose inhalers and methods of use |
| 08/22/2001 | EP1124539A1 Pharmaceutical formulation comprising omeprazole |
| 08/22/2001 | EP1124534A1 Expandable gastroretentive therapeutical system with prolonged stomach retention time |
| 08/22/2001 | CN1309666A Polymer composition of glucuronic acid glucosan |
| 08/22/2001 | CN1309663A Anti-angiogenic proteins and methods of use thereof |
| 08/22/2001 | CN1309657A Use of diazepins for preparing medicines for treating pathological conditions or diseases involving one of growth hormone release inhibiting factor receptors |
| 08/22/2001 | CN1309654A Biphenyl derivs. |
| 08/22/2001 | CN1309641A Quinoline derivs. |
| 08/22/2001 | CN1309640A Quinoline derivs. |
| 08/22/2001 | CN1309638A N-substd. naphthalene carboxamides as neurokinin-receptor antagonists |
| 08/22/2001 | CN1309568A Combination therapy comprising ribavirin and interferon alpha in antiviral treatment naive patients having G chronic hepatitis C infection |
| 08/22/2001 | CN1309556A Biodegradable sustained-release alginate gels |
| 08/22/2001 | CN1308967A Method for producing transgenic plant to express protein in hepatitis B virus envelope and its products |
| 08/22/2001 | CN1308960A Medicine for treating gastrosis |
| 08/22/2001 | CN1308951A Medicine for treating hepatitis B and its preparing process |
| 08/22/2001 | CN1308943A Chinese patent medicine for treating gastritis |
| 08/22/2001 | CN1308935A Medicinal patch for treating hepatism |
| 08/22/2001 | CN1069836C Medicine for treating infantile malnutrition and its preparing process |
| 08/22/2001 | CN1069835C Compsn. for protecting drinker's health and its prodn. method |
| 08/21/2001 | US6277989 Quinazoline derivatives as medicaments |
| 08/21/2001 | US6277977 cDNA clone HAPOI67 that encodes a human 7-transmembrane receptor |
| 08/21/2001 | US6277965 Amino acid sequence of cysteinyl trna (transfer ribonucleic acid) synthetase from chlamydia; bactericides; bacteriostats; enzyme inhibitors; drug screening; diagnosis; vaccines |
| 08/21/2001 | US6277887 Methods for treating Parkinson's disease using optically pure (−)-bupropion |
| 08/21/2001 | US6277876 Antiinflammatory agents; prevent tissue degradation |
| 08/21/2001 | US6277859 Highly selective kappa-opioid agonists useful as analgesics and diuretics with reduced physiological side effects |
| 08/21/2001 | US6277852 Piperazinyl 5-HT1 agonists and antagonists |
| 08/21/2001 | US6277839 Antiinflammatory agents, antipyretics, analgesics; side effect reduction |
| 08/21/2001 | US6277836 Methods and compositions for treating inflammatory bowel disease |
| 08/21/2001 | US6277813 Colostrum derived growth factor |
| 08/21/2001 | US6277412 A core and an enteric coating, the core including, as a pharmaceutical active compound, 5-aminosalicylic acid homogeneously dispersed in a non gel-forming polymer matrix which extends through the entire core |
| 08/21/2001 | CA2294595C Inhibiting bone resorption |
| 08/21/2001 | CA2207348C Benzimidazole derivatives |
| 08/21/2001 | CA2100868C Derivatives of dicarboxylic acids having six to twelve carbon atoms and use of these derivatives and dicarboxylic acids alone in the preparation of pharmaceutical compositions forenteral and parenteral nutrition |
| 08/21/2001 | CA2083606C Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use |
| 08/21/2001 | CA2060652C N-substituted cycloalkyl and polycycloalkyl alpha-substituted trp-phe- and phenethylamine derivatives |